Search
Filter Results
Displaying 11–20 of 1003 results
-
- Nov 2, 2024
- 2:00 PM (CDT)
- 125 N Madison S, Iowa City, IA 52245
Join us for a newly expanded speaker program Vision Connection, an enriching and supportive gathering of the blind and low vision community.
-
- Nov 2, 2024
- 1:00 PM - 3:30 PM (EDT)
- 350 Trolley Line Blvd, Mashantucket, CT 06338
Before and in conjunction with the Hope in Focus Dinner in the Dark event, the Foundation Fighting Blindness would like to invite you to an afternoon Vision Seminar centered on inherited retinal diseases.
-
- Nov 2, 2024
- 10:00 AM (EDT)
- 200 North Lakemont Avenue, Winter Park, FL 32792
Join Our First Orlando Vision Connection!
-
Oct 25, 2024
The RD Fund Announces Ocuphire Pharma’s Acquisition of Opus Genetics
The resulting company will operate under the name Opus Genetics and the Nasdaq ticker symbol (IRD).
-
Oct 25, 2024
Eye on the Cure Podcast | Episode 75: Sharon King
Sharon King, co-founder and president of Taylor’s Tale, talks to host Ben Shaberman about her family’s journey when her daughter Taylor was diagnosed with Batten disease.
-
Ongoing Foundation Fighting Blindness national webinars around the latest research for blinding diseases.
-
Oct 23, 2024
Opus Genetics, Ocuphire Merger to Boost Advancement of Several IRD Gene Therapies
Merger will provide additional capital for gene therapy development.
-
The Foundation’s grants and awards are critical and allow recipients to secure additional and often larger awards from other funding entities like the National Institute of Health.
-
Over the next five years, our focus is to raise awareness of our science initiatives, both within and outside the Foundation, particularly around our research portfolio.
-
To make a bigger impact on our mission to turn early research into clinical trials for people with IRDs and dry AMD, the Foundation will grow its network of collaborators and partners.